Avient (AVNT) Investor presentation summary

Financial performance and business overview

• Achieved 2025 sales of $3.3B, adjusted EPS of $2.82, and adjusted EBITDA of $545M with a 16.7% margin.

• Maintained 15 years of consecutive dividend growth and operates two main segments: Color, Additives & Inks (CAI, 62% of sales) and Specialty Engineered Materials (SEM, 38%).

• Diverse end markets include packaging, consumer, healthcare, defense, building & construction, industrial, transportation, energy, and telecom.

• Regional sales split: US & Canada 40%, EMEA 36%, Asia 18%, Latin America 6%.

• Q1 2026 sales were $847M, with adjusted EBITDA of $150M and margin expansion to 17.7%.

Strategic framework and growth drivers

• Focused on intersecting high-growth markets and secular trends with technology platforms.

• Strategy includes catalyzing core businesses and building new platforms of scale, targeting GDP+ and 10%+ CAGR growth rates.

• Growth vectors aligned to trends like housing shortages, electrification, sustainability, and healthcare innovation.

• Emphasizes portfolio prioritization, innovation, digital transformation, and operational excellence.

• Dedicated resources and talent to manage growth vectors and drive commercial success.

Margin expansion and capital allocation

• Targeting adjusted EBITDA margin expansion to 20%+ through productivity, mix improvement, and operating leverage.

• Pathway includes +400bps margin expansion from 2025 levels, leveraging manufacturing efficiencies and higher-margin sales.

• Disciplined capital allocation: 3-5% of revenue to capex, increasing dividends, net debt/EBITDA target <2.5x, opportunistic share repurchases, and M&A to complement organic growth.